ICD-10-CM Billable Code

E31.23

Multiple endocrine neoplasia [MEN] type IIB

Clinical Classification Guidelines

Medical Intelligence & Overview

Multiple Endocrine Neoplasia Type IIB (MEN IIB) is a rare genetic disorder characterized by the growth of tumors in multiple endocrine glands and other tissues. These tumors can be benign or malignant and often lead to various health complications. Since MEN IIB affects several parts of the body, early recognition and management are essential for improving health outcomes.

Causes & Symptoms

Clinical Causes: MEN IIB is caused by mutations in the RET gene, which is involved in cell growth and division. These genetic changes are inherited in an autosomal dominant pattern, meaning only one copy of the altered gene is enough to cause the disorder. A family history of MEN IIB increases the likelihood of inheriting the condition. Although the exact reasons why these mutations occur are not entirely understood, genetic testing can identify at-risk individuals.

Key Symptoms: People with MEN IIB may experience a variety of symptoms based on the tumors' locations and sizes. Common signs include: - Mucosal neuromas (lumps on the lips, tongue, and inside the mouth) - Marfanoid body habits (tall, slender frame with long limbs) - Medullary thyroid carcinoma (a type of thyroid cancer) - Pheochromocytomas (tumors in the adrenal glands that may cause high blood pressure) - Ganglioneuromas (benign tumors in the nerve tissue) - Skeletal abnormalities These symptoms usually develop during adolescence or early adulthood but can sometimes be present earlier or later in life.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of MEN IIB involves a combination of clinical assessment, family history, and various medical tests: - Physical examination focusing on mucosal neuromas and body habitus - Genetic testing to identify RET mutations - Imaging tests such as ultrasound, MRI, or CT scans to detect tumors in endocrine glands - Biopsy of suspicious growths - Blood and urine tests to evaluate hormone levels Confirming the presence of RET mutations is crucial for establishing the diagnosis and guiding family screening.

Treatment Protocols: Managing MEN IIB typically involves a multidisciplinary approach tailored to the specific tumors and symptoms: - Surgical removal of medullary thyroid carcinoma to prevent cancer spread - Surgical options for adrenal tumors if they cause symptoms or hormone imbalance - Regular monitoring for new tumor development - Medications to control hormone-related symptoms, if present - Genetic counseling for affected families Since MEN IIB is a hereditary condition, relatives of diagnosed individuals are often advised to undergo genetic testing and regular screenings to catch early signs of the disorder.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E31.23 a billable ICD-10 code?
Yes, E31.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E31.23?
Clinical documentation must specify the nature of Multiple endocrine neoplasia [MEN] type IIB and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

endocrine multiple neoplasia